An international research group directed by UMC Utrecht has developed and characterized two first-in-class antibodies that specifically block the high-affinity IgG receptor FcγRI. Their findings open ...
Scripps Research scientists have developed a new class of drug compounds that reduce harmful inflammation while leaving the body's ability to fight infections intact—a long-sought goal in treating ...
Dublin, April 30, 2025 (GLOBE NEWSWIRE) -- The "Inflammatory Bowel Disease Treatment Market - A Global and Regional Analysis: Focus on Route of Administration, Drug Class, Distribution Channel, Type, ...
Nantes, France, April 15, 2026 – 7:30am CEST - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage biotech company dedicated to developing first-in-class therapies in ...
Today's painkillers are effective enough at doing their job, but carry the risk of side effects and negative health impacts – a problem that a new study tackles by homing in on the pain relief part in ...
Inside cells, two important enzymes act like small central regulatory hubs: dipeptidyl peptidase 8 and 9—DPP8/9 for short. Among other things, they regulate inflammatory reactions and influence ...
Stopping tumor growth is only half the battle. Rather than killing tumor cells, many cancer therapies can only push them into ...
Researchers have identified a previously unknown pathway through which growth differentiation factor 15 – a hormone best ...
Chronic inflammation may trigger or worsen depression, especially in those with autoimmune or chronic conditions. Depression is a widespread mental health condition with many possible causes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results